Metabonomic analysis of the therapeutic effect of exendin-4 for the treatment of tBHP-induced injury in mouse glomerulus mesangial cells

References

• Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes. 2007;115:69–84.
   PubMed Web of Science ®Google Scholar
• Taniguchi M, Yoshida H. Endoplasmic reticulum stress in kidney function and disease. Curr Opin Nephrol Hypertens. 2015;24:345–350.
   PubMed Web of Science ®Google Scholar
• Baban B, Liu JY, Mozaffari MS. Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: role of indoleamine 2,3-dioxygenase and programmed death-1. Exp Mol Pathol. 2013;94:343–351.
   PubMed Web of Science ®Google Scholar
• Liu J, Yang JR, Chen XM, et al. Impact of ER stress-regulated ATF4/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy. Am J Physiol Cell Physiol. 2015;308:C621–C630.
   PubMed Web of Science ®Google Scholar
• Miyata T, de Strihou Cv. Diabetic nephropathy: a disorder of oxygen metabolism? Nat Rev Nephrol. 2010;6:83–95.
   PubMed Web of Science ®Google Scholar
• Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14:1358–1373.
   PubMed Web of Science ®Google Scholar
• Kim BH, Lee ES, Choi R, et al. Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of Type 2 diabetic nephropathy. Yonsei Med J. 2016;57:664–673.
   PubMed Web of Science ®Google Scholar
• Lee ES, Kim HM, Kang JS, et al. Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model, Nephrology. Nephrol Dial Transplant. 2016;31:391–400.
   PubMed Web of Science ®Google Scholar
• Chen J, Hou XF, Wang G, et al. Terpene glycoside component from moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses. J Ethnopharmacol. 2016;193:433–444.
   PubMed Web of Science ®Google Scholar
• Cao A, Wang L, Chen X, et al. Ursodeoxycholic acid ameliorated diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress. Biol Pharm Bull. 2016;39:1300–1308.
   PubMed Web of Science ®Google Scholar
• Wang ZS, Xiong F, Xie XH, et al. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress. BMC Nephrol. 2015;16:44.
   PubMed Web of Science ®Google Scholar
• Yao F, Li Z, Ehara T, et al. Fatty acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy. Mol Cell Endocrinol. 2015;411:232–242.
   PubMed Web of Science ®Google Scholar
• Ravindran S, Kuruvilla V, Wilbur K, et al. Nephroprotective effects of metformin in diabetic nephropathy. J Cell Physiol. 2017;232:731–742.
   PubMed Web of Science ®Google Scholar
• Wang L, Tang L, Wang Y, et al. Exendin-4 protects HUVECs from t-BHP-induced apoptosis via PI3K/Akt-Bcl-2-caspase-3 signaling. Endocr Res. 2016;41:229–235.
   PubMed Web of Science ®Google Scholar
• Chen WJ, Wang LX, Wang YP, et al. Exendin-4 Protects min6 cells from t-BHP-Induced Apoptosis via IRE1-JNK-caspase-3 Signaling. Int J Endocrinol. 2012;2012:549081.
   PubMedGoogle Scholar
• Teng Q, Huang W, Collette TW, et al. A direct cell quenching method for cell-culture based metabolomics. Metabolomics. 2009;5:199–208.
   Web of Science ®Google Scholar
• Huang Z, Shao W, Gu J, et al. Effects of culture media on metabolic profiling of the human gastric cancer cell line SGC7901. Mol Biosyst. 2015;11:1832–1840.
   PubMed Web of Science ®Google Scholar
• Lamichhane S, Yde CC, Schmedes MS, et al. Strategy for nuclear-magnetic-resonance-based metabolomics of human feces. Anal Chem. 2015;87:5930–5937.
   PubMed Web of Science ®Google Scholar
• Gu J, Hu X, Shao W, et al. Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis. Oncotarget. 2016;7:60053–60073.
   PubMedGoogle Scholar
• Li M, Wang X, Aa J, et al. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol. 2013;304:F1317–F1324.
   PubMed Web of Science ®Google Scholar
• von Scholten BJ, Lajer M, Goetze JP, et al. Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment. Diabet Med. 2015;32:343–352.
   PubMed Web of Science ®Google Scholar
• Guo H, Li H, Wang B, et al. Protective effects of glucagon-like Peptide-1 analog on renal tubular injury in mice on high-fat diet. Cell Physiol Biochem. 2017;41:1113–1124.
   PubMed Web of Science ®Google Scholar
• Niemann CU, Serkova NJ. Biochemical mechanisms of nephrotoxicity: application for metabolomics. Expert Opin Drug Metab Toxicol. 2007;3:527–544.
   PubMed Web of Science ®Google Scholar
• Zhao L, Gao H, Zhao Y, et al. Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathy. J Ethnopharmacol. 2012;142:647–656.
   PubMed Web of Science ®Google Scholar
• Li Z, Li A, Gao J, et al. Kidney tissue targeted metabolic profiling of unilateral ureteral obstruction rats by NMR. Front Pharmacol. 2016;7:307.
   PubMed Web of Science ®Google Scholar
• Waters NJ, Waterfield CJ, Farrant RD, et al. Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Chem Res Toxicol. 2005;18:639–654.
   PubMed Web of Science ®Google Scholar
• Titov VN, Dmitriev LF, Krylin VA, et al. Methylglyoxal – a test for impaired biological functions of exotrophy and endoecology, low glucose level in the cytosol and gluconeogenesis from fatty acids (a lecture). Klin lab diagn. 2010:22–36.
   Google Scholar
• Gerich JE, Meyer C, Woerle HJ, et al. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care. 2001;24:382–391.
   PubMed Web of Science ®Google Scholar
• Berry GT, Baker L, Kaplan FS, et al. Diabetes-like renal glomerular disease in Fanconi–Bickel syndrome. Pediatr Nephrol. 1995;9:287–291.
   PubMed Web of Science ®Google Scholar
• Du C, Wu M, Liu H, et al. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease. Int J Biochem Cell Biol. 2016;79:1–13.
   PubMed Web of Science ®Google Scholar
• Hao J, Zhu L, Li F, et al. Phospho-mTOR: a novel target in regulation of renal lipid metabolism abnormality of diabetes. Exp Cell Res. 2013;319:2296–2306.
   PubMed Web of Science ®Google Scholar
• Herman-Edelstein M, Scherzer P, Tobar A, et al. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res. 2014;55:561–572.
   PubMed Web of Science ®Google Scholar
• Nieth H, Schollmeyer P. Substrate-utilization of the human kidney. Nature. 1966;209:1244–1245.
   PubMed Web of Science ®Google Scholar
• Hwang GS, Yang JY, Ryu DH, et al. Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1) H-NMR-based metabonomics. Am J Physiol Renal Physiol. 2010;298:F461–F470.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang J, Cai S, et al. Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1H NMR spectroscopy. Anal Bioanal Chem. 2009;393:1657–1668.
   PubMed Web of Science ®Google Scholar
• Qin CX, Sleaby R, Davidoff AJ, et al. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications. Pharmacol Res. 2017;116:45–56.
   PubMed Web of Science ®Google Scholar
• Bosch RR, Janssen SW, Span PN, et al. Exploring levels of hexosamine biosynthesis pathway intermediates and protein kinase C isoforms in muscle and fat tissue of Zucker Diabetic Fatty rats. Endocrine. 2003;20:247–252.
   PubMed Web of Science ®Google Scholar
• Pompella A, Visvikis A, Paolicchi A, et al. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 2003;66:1499–1503.
   PubMed Web of Science ®Google Scholar
• Lash LH. Mitochondrial glutathione in diabetic nephropathy. J Clin Med. 2015;4:1428–1447.
   PubMed Web of Science ®Google Scholar
• Ueno Y, Kizaki M, Nakagiri R, et al. Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J Nutr. 2002;132:897–900.
   PubMed Web of Science ®Google Scholar